UK MHRA’s Clinical Trial Lead On Combined Reviews, The Notification Scheme & Increasing Diversity

 
• By Eliza Slawther
  
The MHRA’s Andrea Manfrin discussed the agency’s plans for clinical trials with the Pink Sheet (MHRA)

More from Interviews

More from Pink Sheet